| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-17 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-14 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-11 |